hepatic encephalopathy HE

Related by string. Hepatic encephalopathy HE * Hepatic : overt hepatic encephalopathy . hepatic resection . ileus pancreatitis hepatic / Encephalopathy : bovine spongiform encephalopathy spreads . bovine spongiform encephalopathy BSE . hypoxic ischemic encephalopathy HIE / hes . Heed . He : HE Sheikh Hamad . HE SAID IT . HE McCracken Middle * overt hepatic encephalopathy HE *

Related by context. All words. (Click for frequent words.) 70 haematologic 69 metastatic uveal melanoma 68 pouchitis 67 malignant ascites 67 metastatic malignant 66 leukemia AML 66 hepatorenal syndrome 66 bullous 66 thrombocytopenic patients 66 antimetabolite 66 acute lymphoblastic 66 cranial irradiation 66 mycosis fungoides 66 acamprosate calcium 66 Chronic lymphocytic leukemia 66 NAGS deficiency 66 antiemetics 65 thrombocytopenic 65 pamidronate 65 secondary hyperparathyroidism 65 EGFRIs 65 recurrent glioblastoma multiforme 65 atypical hemolytic uremic syndrome 65 systemic corticosteroid 65 mycophenolate mofetil MMF 65 diabetic gastroparesis 65 pulmonary hypertension PH 65 familial hypercholesterolemia FH 65 thrombocytosis 65 diabetic kidney 65 HeFH 65 levodopa carbidopa 65 acute mania 65 receptor inhibitor 65 idiopathic thrombocytopenic purpura 65 PPAR gamma agonists 65 erythropoietic 65 lichen planus 65 immunocompetent patients 64 salmeterol fluticasone 64 patientswith 64 malignant lymphomas 64 AGILECT R 64 cutaneous lupus 64 biliary tract cancer 64 clomipramine 64 Alequel 64 pediatric acute lymphoblastic 64 schizophrenia CIAS 64 quetiapine Seroquel 64 lymphocytic leukemia 64 posttransplant 64 nimodipine 64 CIMZIA TM certolizumab pegol 64 non metastatic osteosarcoma 64 overt nephropathy 64 hepatic encephalopathy 64 Toxicities 64 MYLOTARG 64 relapsed AML 64 Carbaglu 64 immune thrombocytopenic purpura ITP 64 hematologic parameters 64 abacavir Ziagen 64 histologic subtype 64 secondary amenorrhea 64 myeloid metaplasia 64 Pemetrexed 64 anagrelide 64 cytopenias 64 EXJADE 64 recurrent glioblastoma 64 eculizumab therapy 64 torsade de pointes 64 relapsed MM 64 sJIA 64 complement inhibitor eculizumab 64 Cimzia TM 63 de novo AML 63 pemphigus vulgaris 63 pimecrolimus cream 63 neovascular 63 generalized tonic clonic seizures 63 migraine prophylaxis 63 pancreatic insufficiency 63 bexarotene 63 Carbamazepine 63 bortezomib Velcade 63 constipation predominant IBS 63 Heavy menstrual bleeding 63 thyrotoxicosis 63 urolithiasis 63 PsA 63 OHR/AVR# 63 urothelial cancer 63 antiangiogenic therapy 63 idarubicin 63 constipation OIC 63 CYP #A# 63 alefacept 63 smoldering myeloma 63 divalproex sodium 63 inotropes 63 artery stenosis 63 SGPT 63 venous stasis ulcers 63 vaso occlusive crisis 63 ocular inflammatory 63 sitaxsentan 63 symptomatic paroxysmal AF 63 FOSRENOL ® 63 thalidomide Thalomid 63 immunomodulation 63 corticosteroid therapy 63 plasminogen activators 63 myeloproliferative diseases 63 C1 INH deficiency 63 invasive candidiasis 63 cirrhotic liver 63 postoperative AF 63 levodopa induced 63 anticholinergic agents 63 metastatic lung cancer 63 alpha interferons 63 partial onset seizures 63 T1DM 63 bladder carcinoma 63 nonalcoholic steatohepatitis NASH 63 Abrupt discontinuation 63 Vidaza azacitidine 63 overactive bladder syndrome 63 neutropaenia 63 Crohns disease 63 Sjögren syndrome 63 TNF alpha inhibitor 63 endothelial activation 63 cardiotoxic 63 interstitial pneumonitis 63 virally induced 63 GH deficiency 63 MELAS syndrome 63 levodopa therapy 63 thiopurine 63 Decitabine 63 delayed CINV 63 metaplasia 63 mecamylamine 63 allogeneic HSCT 63 denileukin diftitox 63 gastrointestinal stromal tumors GIST 63 conventional DMARDs 63 anemia neutropenia 63 intracranial hemorrhage ICH 63 HbF 63 chronic thromboembolic pulmonary 63 leukemia ALL 62 medically refractory 62 imatinib resistance 62 antiarrhythmic 62 ANCA associated 62 myelosuppressive 62 mycophenolate 62 follicular lymphoma FL 62 perioperatively 62 coagulopathy 62 parasitemia 62 candidemia 62 ara C 62 verteporfin 62 rituximab Rituxan 62 refractory anaplastic astrocytoma 62 prospectively enrolled 62 Gleevec resistant 62 EFFEXOR XR 62 thromboembolic disease 62 neovascularisation 62 basal cell nevus syndrome 62 glucocorticoid therapy 62 CTEPH 62 osteosarcomas 62 elevated LDH 62 keloid scarring 62 liver metastasis 62 Cimzia ® certolizumab pegol 62 atopic dermatitis AD 62 nasal polyposis 62 extrapyramidal symptoms 62 primary hyperparathyroidism 62 systemic amyloidosis 62 moderately emetogenic 62 colorectal adenoma 62 preterm neonates 62 ischemic mitral regurgitation 62 visilizumab 62 cilengitide 62 idiopathic thrombocytopenic purpura ITP 62 flutamide 62 diabetic polyneuropathy 62 metastatic malignant melanoma 62 hyperoxaluria 62 antiandrogen 62 Myelodysplastic Syndrome MDS 62 Cognitive dysfunction 62 MELAS 62 lupus nephritis 62 efalizumab 62 SIADH 62 eosinophilic asthma 62 hypocalcaemia 62 choroidal vasculopathy 62 Adjuvant chemotherapy 62 pancreatic adenocarcinoma 62 immunosuppressives 62 pretransplant 62 AChE inhibitors 62 cinacalcet 62 acute gout 62 Prostatitis 62 diabetes mellitus DM 62 cough dyspnea 62 antiepileptics 62 chronic urticaria 62 immunosuppressive regimen 62 Dacogen decitabine 62 atrioventricular block 62 antithrombotic therapy 62 acne vulgaris 62 rFVIIa 62 hepatic toxicity 62 parkinsonian 62 indolent lymphomas 62 juvenile idiopathic arthritis JIA 62 neuroleptic 62 AGHD 62 comorbid disorders 62 neurocognitive deficits 62 tricyclic antidepressant 62 Kinoid 62 idiopathic PAH 62 Hypotension 62 mixed hyperlipidemia 62 anterior uveitis 62 HIV lipodystrophy 62 RAS mutations 62 Nebulized 62 metastatic carcinoid tumors 62 RezularTM 62 oxcarbazepine 62 Lamotrigine 62 intravenous cyclophosphamide 62 macroalbuminuria 62 INVEGA ® 62 TMP SMX 62 rufinamide 62 hypercalciuria 62 untreated celiac disease 62 pheochromocytoma 62 antithyroid 62 CIMZIA ™ 62 MCyR 62 nephrotoxicity 62 MYCN amplification 62 bacterial prostatitis 62 vWD 62 CRVO 62 metastatic neuroendocrine tumors 62 allograft rejection 62 ZOLINZA 62 antirheumatic 62 decompensated cirrhosis 62 canakinumab 62 serum urate levels 62 pentoxifylline 62 demyelinating 62 induce orthostatic hypotension 62 deletion 5q 62 β blockers 61 fistulizing Crohn disease 61 atherothrombotic 61 INVEGA SUSTENNA 61 multi infarct dementia 61 carcinoid tumors 61 autoimmune thyroiditis 61 liver histology 61 histological subtype 61 reflux esophagitis 61 polymyalgia rheumatica 61 cerebral vasospasm 61 neurological manifestations 61 metastatic bladder 61 refractory acute myeloid 61 icatibant 61 postsurgical pain 61 cytopenia 61 unfavorable cytogenetics 61 Helicobacter pylori eradication 61 Surgical resection 61 HIV HCV coinfected 61 carcinoids 61 neuroleptics 61 Cognitive impairment 61 basiliximab 61 dysfunctional voiding 61 Squalamine 61 Parnate 61 refractory AML 61 neurologic sequelae 61 Tasimelteon 61 Synovial sarcoma 61 overactive bladder symptoms 61 Venous thromboembolism 61 HSCT 61 purpura 61 metabolic disturbances 61 colorectal liver metastases 61 interstitial fibrosis 61 Barrett esophagus BE 61 Alzheimer Disease AD 61 neurodevelopmental impairment 61 idiopathic pulmonary arterial hypertension 61 tranylcypromine 61 primary aldosteronism 61 dyskinetic 61 vesicoureteral reflux 61 benign prostatic hypertrophy BPH 61 erythema nodosum 61 chronic immune thrombocytopenic 61 gastric adenocarcinoma 61 CIMZIA R 61 AMEVIVE 61 calcineurin inhibitors 61 hypercalcemia 61 cardiac repolarization 61 inhaled liposomal ciprofloxacin 61 immune modulating 61 Insulin detemir 61 interferon ribavirin 61 Clinically significant 61 hepatic insufficiency 61 chronic periodontitis 61 post herpetic neuralgia PHN 61 relapsed ALL 61 nonprogressive 61 mucosal inflammation 61 transaminase elevations 61 SPRYCEL ® 61 comorbid depression 61 oral prednisolone 61 hepatic enzyme 61 menopausal symptom 61 tolterodine ER 61 severe exacerbations 61 sargramostim 61 hematological toxicity 61 Chronic pancreatitis 61 biologic therapy 61 lenalidomide dexamethasone 61 idiopathic pulmonary 61 elevated IOP 61 Fludarabine 61 Natalizumab 61 SSc 61 malignant neoplasm 61 thymic carcinoma 61 Bosentan 61 CYT# potent vascular disrupting 61 invasive aspergillosis 61 atypical neuroleptics 61 anthracycline chemotherapy 61 hyperprolactinemia 61 neuropsychiatric symptoms 61 thyroid deficiency 61 chronic renal insufficiency 61 dysfunction LVSD 61 leucopenia 61 IBS C 61 squamous cell lung cancer 61 interstitial pneumonia 61 CHOP chemotherapy 61 noninfectious uveitis 61 VFEND 61 hA# 61 tumor histology 61 octreotide LAR 61 selective modulator 61 Serious adverse reactions 61 Etanercept 61 systemic hypotension 61 ziconotide 61 diabetic retinopathy DR 61 growth hormone secretion 61 adrenal function 61 ER CHOP 61 nitrofurantoin 61 pleurodesis 61 chronic granulomatous disease 61 chronic myeloid 61 Acute myeloid leukemia 61 Vitamin B# deficiency 61 thrombotic complications 61 Flu Cy 61 NMDA receptor antagonist 61 paricalcitol 61 sensory neuropathy 61 hypoparathyroidism 61 deep venous thromboses 61 generalized anxiety disorder GAD 61 miglustat 61 infliximab Remicade 61 achalasia 61 erosive GERD 61 oral anticoagulant therapy 61 antihypertensive therapy 61 LV dysfunction 61 long acting bronchodilator 61 pseudotumor cerebri 61 affective psychosis 61 hepatic cirrhosis 61 urothelial carcinoma 61 ADHD stimulant 61 OSAHS 61 dual endothelin receptor antagonist 61 bronchial hyperresponsiveness 61 ovarian carcinoma 61 discoid lupus 61 lymphopenia 61 myoclonus 61 hyperphenylalaninemia HPA due 61 pyridostigmine 61 polymicrobial infections 61 platelet inhibitor 61 clotrimazole 61 Velcade bortezomib 61 Zollinger Ellison syndrome 61 fibromyalgia syndrome 61 dyskeratosis congenita 61 Neovascular AMD 61 vascular abnormalities 61 immune thrombocytopenic purpura 61 gallium nitrate 61 milrinone 61 psoriasis vulgaris 61 ulcerative colitis UC 61 calcineurin inhibitor 61 sarcomatoid 61 hypercalcaemia 61 carcinomatosis 61 Interferon beta 61 immuno modulatory 61 fructose intolerance 61 ischemic cardiomyopathy 61 certolizumab 61 PAOD 61 chronic eosinophilic leukemia 61 polycythemia vera essential thrombocythemia 61 glatiramer acetate GA 61 nausea vomiting headache 61 Atypical antipsychotics 61 cystic fibrosis chronic pancreatitis 61 Papillary 61 juvenile idiopathic arthritis 61 skeletal metastases 61 chronic rheumatic 60 G6PD deficiency 60 Alequel ™ 60 caspofungin 60 progressive dyspnea 60 Hypertrophic 60 recurrent genital herpes 60 ELACYT 60 subependymal giant cell 60 aspirin clopidogrel 60 treating neuropathic pain 60 weekly intravenous infusions 60 BARACLUDE ® 60 Glioblastoma Multiforme GBM 60 neurocognitive impairment 60 Inhaled nitric oxide 60 Severe Primary IGFD 60 intratympanic 60 HBeAg negative 60 vasospasm 60 H2 antagonists 60 Nonspecific 60 Sydenham chorea 60 noncancer pain 60 intestinal polyps 60 ALI ARDS 60 galantamine 60 Infusion Reactions Severe 60 bronchodilatory 60 INVEGA ® SUSTENNA TM 60 olmesartan 60 acitretin 60 acromegalic patients 60 recurrent glioblastoma multiforme GBM 60 induce remission 60 NMIBC 60 hypereosinophilic syndrome 60 systemic lupus erythematosus 60 chronic renal disease 60 acute myeloid 60 tumor regressions 60 biologic DMARD 60 neutropenic 60 Hurler syndrome 60 unresectable tumors 60 ischemic cardiac 60 acute GvHD 60 lesional 60 euthymic patients 60 inhibitor RG# 60 euthyroid 60 somatostatin analogs 60 anticancer treatments 60 adjuvant cisplatin 60 preserved ejection fraction 60 apneic episodes 60 fibrosing 60 neurosensory 60 acute renal 60 GOUT 60 LHRH agonists 60 ankylosing spondylitis AS 60 pharmacological therapies 60 pharmacologic treatments 60 KRAS mutations occur 60 inhaled bronchodilators 60 ACTEMRA TM 60 adriamycin 60 CR nPR 60 LNG IUS 60 anemias 60 Lupus nephritis 60 proliferative retinopathy 60 Leber congenital amaurosis LCA 60 myeloablative 60 null responder 60 metastatic renal 60 surgical debulking 60 LHRH agonist 60 hemodialysis patients 60 comorbid psychiatric 60 lipid altering 60 non splenectomized 60 proliferative diabetic retinopathy 60 headache abdominal pain 60 topical calcineurin inhibitors 60 atopic disease 60 homozygous familial hypercholesterolemia 60 Actimmune ® 60 dorzolamide 60 CsA 60 opioid dependent 60 Legg Calvé Perthes disease 60 Topical corticosteroids 60 hematopoietic cancers 60 imiquimod cream 60 paroxysmal nocturnal hemoglobinuria 60 Perforomist ™ Inhalation Solution 60 neutropenic patients 60 oesophagitis 60 Teriflunomide 60 prescribed proton pump 60 chronic neuropathic pain 60 Genentech Rituxan 60 trastuzumab Herceptin ® 60 hyperalgesia 60 nicardipine 60 generalized seizures 60 tuberous sclerosis TS 60 prucalopride 60 clevidipine 60 sacral nerve stimulation 60 pegylated liposomal doxorubicin 60 membranous nephropathy 60 briakinumab 60 esophageal candidiasis 60 prolonged cytopenias 60 radiochemotherapy 60 hematologic toxicity 60 hepatic fibrosis 60 antiepileptic medications 60 neuro psychiatric disorders 60 dopamine partial agonist 60 Elevated serum 60 choroidal neovascularization 60 tacrolimus ointment 60 ductal adenocarcinoma 60 dermatologic reactions 60 heFH 60 hematologic disorders 60 Myelodysplastic syndromes MDS 60 vWF 60 multiple myeloma MM 60 liposomal amphotericin B 60 anticholinergic medication 60 pegaptanib 60 rheumatic disease 60 opioid induced constipation 60 KETEK 60 AGILECT ® 60 serum cortisol 60 Diabetic nephropathy 60 Heterozygous Familial Hypercholesterolemia 60 hyperammonemia 60 Kepivance 60 vidofludimus 60 esophagitis 60 superficial bladder cancer 60 4mg/kg 60 ATACAND 60 anemia thrombocytopenia 60 mood dysregulation 60 venlafaxine Effexor 60 cisplatin chemotherapy 60 doxorubicin HCl 60 primary immunodeficiency PI 60 mecasermin 60 idiopathic Parkinson disease 60 post herpetic neuralgia 60 anti angiogenic agents 60 cirrhotic 60 oral anticoagulation 60 valvular heart disease 60 neurocognitive outcomes 60 orchitis 60 Topiramate 60 Xyfid TM 60 dysmenorrhoea 60 griseofulvin 60 vesicoureteral reflux VUR 60 Sezary syndrome 60 IOP lowering 60 Carbidopa 60 psychiatric comorbidity 60 Impaired glucose tolerance 60 PNH patients 60 endometrial hyperplasia 60 Chronic Prostatitis 60 Nicotine dependence 60 Noxafil 60 bronchogenic carcinoma 60 dopaminergic therapy 60 premenstrual dysphoric disorder PMDD 60 hypocalcemia 60 receiving VICTRELIS 60 Mitoxantrone 60 CP CPPS 60 benign neoplasms 60 cell lymphoma CTCL 60 chemoradiation therapy 60 riociguat 60 anticonvulsants 60 antiarrhythmic medications 60 MULTAQ 60 maximally tolerated lipid lowering 60 phenothiazines 60 esophageal gastric 60 gastrointestinal perforation 60 lysosomal storage disease 60 acute coronary syndromes ACS 60 haematological toxicity 60 Medullary thyroid cancer 60 nonischemic 60 myelodysplastic myeloproliferative diseases 60 asplenia 60 adverse cytogenetics 60 Eisenmenger syndrome 60 mitomycin C 60 Fenretinide 60 gefitinib Iressa 60 VAPRISOL 60 gross hematuria 60 ß blockers 60 cytogenetic abnormalities 60 antithrombotics 60 inflammatory bowel syndrome 60 Levetiracetam 60 diaper dermatitis 60 AA Amyloidosis 60 hyperacute 60 CYP#D# inhibitor 60 myeloproliferative neoplasms 60 chronic GVHD 60 hepatic metastases 60 pancreatic carcinoma 60 neurogenic 60 antiandrogens 60 Hydroxyurea 60 anthracyclines taxanes 60 LOVENOX R 60 hepatocellular 60 hypophosphatemia 60 cryptogenic 60 imexon 60 veno occlusive disease 60 aminotransferases 60 methotrexate monotherapy 60 onset diabetes mellitus 60 thrombolytic agents 60 Chronic Myelogenous Leukemia CML 60 squamous cell carcinoma SCC 60 ORENCIA ® 60 Crohn disease CD 60 potentially hepatotoxic 60 vitreous hemorrhage 60 recombinant erythropoietin 60 oral vancomycin 60 malabsorptive 60 inflammatory lesions 60 tegaserod 60 Cognitive behavioral 60 Plaquenil 60 myelodysplastic syndrome MDS 60 Ménière disease 60 T2DM 60 immunomodulatory agents 60 Atopic dermatitis 60 Certolizumab pegol 60 leukocyte counts 60 papillary renal cell carcinoma 60 diabetic peripheral neuropathy DPN 59 concomitant AEDs 59 corifollitropin alfa 59 adjunctive placebo 59 pulmonary toxicity 59 pathologic myopia 59 decitabine 59 knee osteoarthritis OA 59 Lafora disease 59 adalimumab Humira 59 histologically proven 59 methimazole 59 ‰ ¥ 59 status asthmaticus 59 MIRAPEX 59 paroxysmal AF 59 steroid refractory 59 TNF alpha antagonist 59 ocular allergy 59 recurrent herpes labialis 59 chronic idiopathic thrombocytopenic purpura 59 systemic corticosteroids 59 polyarticular 59 DPNP 59 Irritable Bowel Syndrome IBS 59 hypoperfusion 59 tolterodine 59 FluCAM arm 59 myopathy rhabdomyolysis 59 FOLFIRI alone 59 neutropenic sepsis 59 gastrointestinal stromal tumor 59 papillary thyroid carcinoma 59 primary IGFD 59 Temsirolimus 59 neutropenia thrombocytopenia 59 metastatic bone 59 MYCAMINE 59 uterine fibroid 59 Glucocorticoids 59 AVONEX ® 59 parkinsonian symptoms 59 immunosuppressed patients 59 TMS Therapy 59 Lennox Gastaut Syndrome 59 acute leukemias 59 familial hypercholesterolemia 59 adrenal insufficiency 59 hemoptysis 59 rhIGF-I/rhIGFBP-3 59 selegiline 59 hyperosmolar 59 immunosuppressive therapies 59 chronic idiopathic 59 clobazam 59 genotypic resistance 59 Hashimoto thyroiditis 59 refractory gout 59 IL 1ß 59 inhaled budesonide 59 levetiracetam Keppra 59 monoclonal gammopathy 59 infantile spasms 59 bulbar 59 6R BH4 59 idiopathic myelofibrosis 59 Desmopressin 59 receptor blocker 59 induced anemia 59 receiving ISENTRESS 59 systemic JIA 59 leukoencephalopathy 59 cis retinoic acid 59 lipid lowering agents 59 crohn disease 59 TEMODAL 59 corticosteroid dexamethasone 59 Parkinson Disease PD 59 alveolar rhabdomyosarcoma 59 imatinib Gleevec 59 mycophenolate mofetil 59 plasma uric acid 59 Acute Coronary Syndromes ACS 59 gastro oesophageal reflux 59 cytoreduction 59 FVIII inhibitors 59 vasoactive 59 MALT lymphoma 59 subsyndromal 59 pulmonary resection 59 rheumatic disorders 59 hamartomas 59 INCB# [003] 59 aminotransferase 59 pancytopenia 59 renal scarring 59 mitoxantrone plus 59 arthropathy 59 Evoltra ® 59 Adjunctive 59 unresectable HCC 59 mercaptopurine 59 bronchoalveolar lavage 59 ARCALYST ® 59 myeloproliferative disorder 59 RISPERDAL ® 59 CellCept mycophenolate mofetil 59 metabolic abnormality 59 hMG 59 hypercholesterolaemia 59 adjuvant systemic 59 receiving highly emetogenic 59 squamous histology 59 thyroid carcinoma 59 onset seizures 59 BH4 deficiency 59 syncope fainting 59 NSAID induced 59 tardive dyskinesia TD 59 Zemplar Capsules 59 epoetin alpha 59 Tolvaptan 59 hypercoagulable 59 alpha1 antitrypsin deficiency 59 piperacillin tazobactam 59 voiding dysfunction 59 prostate cancer PCa 59 intermittent claudication 59 hepatotoxic 59 interferon beta 1b 59 Torsades de Pointes 59 uricase 59 Hodgkin lymphoma NHL 59 repolarization 59 topically administered 59 GISTs 59 microsatellite instability 59 radicular pain 59 relapsing multiple sclerosis 59 lanreotide 59 gastroduodenal 59 paresthesias 59 ALT flares 59 postoperative morbidity 59 severe hypersensitivity reactions 59 Fingolimod 59 zaleplon 59 intermittent dosing 59 intravascular hemolysis 59 neuronal dysfunction 59 BENICAR HCT 59 Ophena TM 59 opioid analgesia 59 pulmonary dysfunction 59 symptomatic VTE 59 psychopharmacologic 59 refractory metastatic colorectal cancer 59 micafungin 59 Degarelix 59 TTR amyloidosis 59 etanercept Enbrel 59 desvenlafaxine succinate 59 renoprotective 59 TEAEs 59 Sjogren Syndrome 59 ibandronate 59 trans retinoic acid 59 heavily pretreated 59 â ‰ ¥ 59 antiarrhythmic drugs 59 remission induction 59 neurocognitive impairments 59 bisoprolol 59 Effexor venlafaxine 59 rALLy 59 demonstrated antitumor activity 59 Neovascular Age Related Macular 59 olanzapine LAI 59 COPD exacerbation 59 antibody MAb 59 cystoid macular edema 59 ADPKD 59 intravitreal bevacizumab 59 DMSA 59 eosinophilia 59 HNSCC 59 pan HDAC inhibitor 59 APTIVUS r 59 Doxil ® 59 symptomatic intracranial 59 Intra arterial 59 PTLD 59 ® lenalidomide 59 renal calculi 59 cytogenetic responses 59 paroxysmal atrial fibrillation 59 tigecycline 59 Anti VEGF 59 cardioprotection 59 hepatotoxicity 59 nonproliferative 59 antiphospholipid syndrome 59 Arranon 59 elevated ALT 59 pramipexole Mirapex 59 plasma pharmacokinetics 59 mitochondrial toxicity 59 hepatic failure 59 tipranavir ritonavir 59 prostate carcinoma 59 airway hyper responsiveness 59 TPMT 59 forodesine 59 tumor lysis syndrome 59 rotigotine transdermal patch 59 opioid induced bowel dysfunction 59 prostate cancer CaP 59 orofacial pain 59 neovascular diseases 59 aprepitant 59 mutated K ras 59 A1PI 59 doxorubicin Adriamycin 59 gastrointestinal disturbances 59 Primary IGFD 59 cytomegalovirus infection 59 recurrent UTI 59 Febrile neutropenia 59 Waldenstrom macroglobulinemia 59 oral levofloxacin 59 reflux symptoms 59 infective endocarditis 59 carcinoid syndrome 59 Ribavirin causes 59 mometasone furoate 59 Traficet EN 59 neurodevelopmental disability 59 postherpetic neuralgia PHN 59 erythematosus SLE 59 idraparinux 59 prokinetic 59 thymoma 59 generalized epilepsy 59 Glypromate 59 treat chronic sinusitis 59 progressive neurodegenerative disorder 59 generation purine nucleoside 59 pericardial effusion 59 PCNSL 59 rebleeding 59 neurogenic bladder 59 androgen ablation 59 reflux disease 59 Candida infection 59 autoimmune hemolytic anemia 59 uncontrolled seizures 59 Chronic myeloid leukemia 59 Zarnestra 59 seborrheic dermatitis 59 acetonide FA 59 adrenal suppression 59 paraneoplastic 59 hippocampal atrophy 59 deferiprone 59 congenital deficiency 59 headache nasopharyngitis 59 multisystemic 59 Aortic stenosis 59 Thal Dex 59 neoplasias 59 fluticasone salmeterol 59 immunomodulatory therapy 59 enlarged spleens 59 Chemotherapy induced 59 biliary tract cancers 59 tamoxifen Nolvadex ® 59 neurologic symptoms

Back to home page